Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TBC1 domain family member 3 pseudogene 6 (TBC1D3P6) is a member of the TBC1D3 pseudogene subfamily specific to primate genomes. As a pseudogene, it does not encode a functional protein and is not implicated in human disease or pharmacologic mechanisms. While some pseudogenes are known to regulate the expression of related functional genes or act as competing endogenous RNAs, there is no validated evidence supporting a biological or clinical role for TBC1D3P6. It is not considered a drug target, disease biomarker, or involved in known molecular pathways[5][3]. Key points: - TBC1D3P6 is classified as a pseudogene, meaning it is a nonfunctional genomic sequence similar to protein-coding genes[5][3]. - It does not have an established biological function, disease association, or therapeutic targeting potential. - No drugs, biomarkers, or safety concerns are associated with this pseudogene. If you require information on the functional TBC1D3 gene family or its role in cellular processes such as macropinocytosis, that would refer to "TBC1 domain family member 3" (TBC1D3), which is distinct from TBC1D3P6 and does participate in cell signaling and endocytosis in primates[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TBC1 domain family member 3 pseudogene 6 (TBC1D3P6).